Heather Rowe Armstrong Joins Arcutis as Vice President of Investor Relations and Corporate Communications

WESTLAKE VILLAGE, Calif., March 05, 2020 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that Heather Rowe Armstrong has joined the company as Vice President of Investor Relations and Corporate Communications. In this role, Ms. Armstrong will be responsible for communicating Arcutis? business objectives and accomplishments to all key stakeholders, including shareholders, the global investment community, media and employees.